Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Multiple Oral Doses of Carbamazepine on the Single-oral-dose Pharmacokinetics of Nerandomilast in Healthy Male Trial Participants (an Open-label, Two-treatment, Two- Period Fixed Sequence Trial)

NCT07100964 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT07100964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07100964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Multiple Oral Doses of Carbamazepine on the Single-oral-dose Pharmacokinetics of Nerandomilast in Healthy Male Trial Participants (an Open-label, Two-treatment, Two- Period Fixed Sequence Trial)
Lead sponsor
Boehringer Ingelheim
Phase
Phase 1
Overall status
Completed
Start date
August 11, 2025
Completion date
October 1, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy